Trends in Cardiovascular Medicine
Volume 15, Issue 1 , Pages 1-8 , January 2005

Role of Progenitor Cells in Transplant Arteriosclerosis

  • Jan-Luuk Hillebrands

      Affiliations

    • Corresponding Author InformationAddress correspondence to: J.L. Hillebrands, PhD, Dept. of Cell Biology, Section Immunology & Histology, University Medical Center Groningen (UMCG), A. Deusinglaan 1, NL-9713 AV Groningen, The Netherlands. Tel.: (+31) 050-3638995; fax: (+31) 05f0-3632512.
    • ,
  • Geanina Onuta
    • ,
  • Jan Rozing

References 

  1. Atkinson C, Horsley J, Rhind-Tutt S, et al. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. J Heart Lung Transplant. 2004;23:427–435
  2. Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial—mesenchymal transdifferentiation: in vitro analysis. Circ Res. 2002;90:1189–1196
  3. Fujiyama S, Amano K, Uehira K, et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res. 2003;93:980–989
  4. Glaser R, Lu MM, Narula N, Epstein JA. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation. 2002;106:17–19
  5. Grimm PC, Nickerson P, Jeffery J, et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med. 2001;345:93–97
  6. Gulati R, Jevremovic D, Peterson TE, et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation. 2003;108:1520–1526
  7. Gulati R, Jevremovic D, Witt TA, et al. Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells. Am J Physiol Heart Circ Physiol. 2004;287:H512–H517
  8. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605–612
  9. Hillebrands JL, van den Hurk BMH, Klatter FA, et al. Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis. J Heart Lung Transplant. 2000;19:1183–1192
  10. Hillebrands JL, Klatter FA, Raué HP, et al. Intrathymic immune modulation prevents acute rejection but not the development of graft arteriosclerosis (chronic rejection). Transplantation. 2001;71:914–924
  11. Hillebrands JL, Klatter FA, van den Hurk BMH, et al. Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest. 2001;107:1411–1422
  12. Hillebrands JL, Klatter FA, Nieuwenhuis P, Rozing J. Blood-borne origin of neointimal smooth muscle cells in transplant arteriosclerosis. Graft. 2002;5:161–163
  13. Hillebrands JL, Klatter FA, van Dijk WD, Rozing J. Bone-marrow does not contribute substantially to endothelial cell replacement in transplant arteriosclerosis. Nat Med. 2002;8:194–195
  14. Hillebrands JL, Klatter FA, Rozing J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:380–387
  15. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med. 2003;13:201–206
  16. Hruban RH, Long PP, Erlman EJ, et al. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol. 1993;142:975–980
  17. Hu Y, Davison F, Zhang Z, Xu Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation. 2003;108:3122–3127
  18. Hu Y, Zhang Z, Torsney E, et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in apoE-deficient mice. J Clin Invest. 2004;113:1258–1265
  19. Kisseberth WC, Brettingen NT, Lohse JK, Sandgren EP. Ubiquitous expression of marker transgenes in mice and rats. Dev Biol. 1999;214:128–138
  20. Lagaaij EL, Cramer-Konijnenburg GF, van Kemenade FJ, et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet. 2001;357:33–37
  21. Li J, Han X, Jiang J, et al. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am J Pathol. 2001;158:1943–1947
  22. Libby P, Pober JS. Chronic rejection. Immunity. 2001;14:387–397
  23. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000;105:71–77
  24. Medawar PB. Transplantation of tissues and organs: introduction. Br Med Bull. 1965;21:97–99
  25. Nieuwenhuis P, Hillebrands JL, Rozing J. Chronic allograft rejection associated vasculopathy and synthetic biodegradable vascular grafts: a lesson to learn?. Crit Rev Immunol. 2000;20:85–88
  26. O'Connell JB, Renlund DG, Bristow MR, Hammond E. Detection of allograft endothelial cells of recipient origin following ABO-compatible, nonidentical cardiac transplantation. Transplantation. 1991;51:438–442
  27. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001;98:10,344–10,349
  28. Orosz CG, Pelletier RP. Chronic remodeling pathology in grafts. Curr Opin Immunol. 1997;9:676–680
  29. Plissonnier D, Nochy D, Poncet P, et al. Sequential immunological targeting of experimental arterial allograft. Transplantation. 1995;60:414–424
  30. Pober JS. Is host endothelium a silver lining for allografts?. Lancet. 2001;357:2–3
  31. Poulsom R, Alison MR, Forbes SJ, Wright NA. Adult stem cell plasticity. J Pathol. 2002;197:441–456
  32. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med. 2002;346:5–15
  33. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702–712
  34. Rehman J, Li J, Orschell CM, March KL. Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003;107:1164–1169
  35. Religa P, Bojakowski K, Maksymowicz M, et al. Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries. Transplantation. 2002;74:1310–1315
  36. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809
  37. Sartore S, Chiavegato A, Faggin E, et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res. 2001;89:1111–1121
  38. Sata M, Maejima Y, Adachi F, et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol. 2000;32:2097–2104
  39. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403–409
  40. Sedmak DD, Sharma HM, Czajka CM, Ferguson RM. Recipient endothelialization of renal allografts. An immunohistochemical study utilizing blood group antigens. Transplantation. 1988;46:907–910
  41. Shimizu K, Sugiyama S, Aikawa M, et al. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med. 2001;7:738–741
  42. Simper D, Stalboerger PG, Panetta CJ, et al. Smooth muscle progenitor cells in human blood. Circulation. 2002;106:1199–1204
  43. Simper D, Wang S, Deb A, et al. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant arteriosclerosis. Circulation. 2003;107:r133–r139
  44. Stump MM, Jordan GL, de Bakey ME, Harpert B. Endothelium grown from circulating blood on isolated intravascular dacron hub. Am J Pathol. 1963;43:361–367
  45. Tanaka K, Sata M, Hirata Y, Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 2003;93:783–790
  46. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002;297:2256–2259
  47. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002;105:3017–3024
  48. Werner N, Junk S, Laufs U, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res. 2003;93:e17–e24
  49. Wong CK, Yeung AC. The topography of intimal thickening and associated remodeling pattern of early transplant coronary disease: influence of pre-existent donor atherosclerosis. J Heart Lung Transplant. 2001;20:858–864
  50. Xu W, Baelde HJ, Lagaaij EL, et al. Endothelial cell chimerism after renal transplantation in a rat model. Transplantation. 2002;74:1316–1320
  51. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000;408:92–96
  52. Yousem SA, Sonmez-Alpan E. Use of biotinylated DNA probe specific for the human Y chromosome in the evaluation of the allograft lung. Chest. 1991;99:275–279

PII: S1050-1738(04)00153-7

doi: 10.1016/j.tcm.2004.10.002

Trends in Cardiovascular Medicine
Volume 15, Issue 1 , Pages 1-8 , January 2005

Article Tools

* Image Usage & Resolution